Furthermore, the use of IL-1 and/or TNF-α inhibitors in experimental models of inflammatory arthritis and OA has provided strong support for the role of IL-1 in the regulation of catabolic events and inflammatory processes in degenerative joint diseases [59]. This evidence concerns the gene TNF and osteoarthritis.